Final Exam and Certification

Final Exam and Certification

comprehensive assessment across biology, evidence, safety, and regulation

this final assessment covers GLP-1 receptor biology, molecular engineering, clinical trial evidence across obesity, cardiovascular, diabetes, and kidney outcomes, safety monitoring, dosing, regulatory landscape, and comparative efficacy.